Investigation of Recessive Effects of Coding Variants on Common Clinical Phenotypes in Exome-Sequenced UK Biobank Participants
- PMID: 38342085
- DOI: 10.1159/000537771
Investigation of Recessive Effects of Coding Variants on Common Clinical Phenotypes in Exome-Sequenced UK Biobank Participants
Abstract
Introduction: Previous studies have demonstrated effects of rare coding variants on common, clinically relevant phenotypes although the additive burden of these variants makes only a small contribution to overall trait variance. Although recessive effects of individual homozygous variants have been studied, little work has been done to elucidate the impact of rare coding variants occurring together as compound heterozygotes.
Methods: In this study, attempts were made to identify pairs of variants likely to be occurring as compound heterozygotes using 200,000 exome-sequenced subjects from the UK Biobank. Pairs of variants, which were seen together in the same subject more often than would be expected by chance, were excluded as it was assumed that these might be present in the same haplotype. Attention was restricted to variants with minor allele frequency ≤0.05 and to those predicted to alter amino acid sequence or prevent normal gene expression. For each gene, compound heterozygotes were assigned scores based on the rarity and predicted functional consequences of the constituent variants and the scores were used in a logistic regression analysis to test for association with hypertension, hyperlipidaemia, and type 2 diabetes.
Results: No statistically significant associations were observed and the results conformed to the distribution, which would be expected under the null hypothesis. The average number of apparently compound heterozygous subjects for each gene was only 282.2.
Conclusion: It seems difficult to detect an effect of compound heterozygotes on the risk of these phenotypes. Even if recessive effects from compound heterozygotes do occur, they would only affect a small number of people and overall would not make a substantial contribution to phenotypic variance. This research has been conducted using the UK Biobank Resource.
Keywords: Compound heterozygote; Exome; Recessive effects.
© 2024 The Author(s). Published by S. Karger AG, Basel.
Similar articles
-
Exome-wide evidence of compound heterozygous effects across common phenotypes in the UK Biobank.Cell Genom. 2024 Jul 10;4(7):100602. doi: 10.1016/j.xgen.2024.100602. Epub 2024 Jun 28. Cell Genom. 2024. PMID: 38944039 Free PMC article.
-
Weighted burden analysis of rare coding variants in 470,000 exome-sequenced UK Biobank participants characterises effects on hyperlipidaemia risk.J Hum Genet. 2024 Jun;69(6):255-262. doi: 10.1038/s10038-024-01235-8. Epub 2024 Mar 7. J Hum Genet. 2024. PMID: 38454133 Free PMC article.
-
In trans variant calling reveals enrichment for compound heterozygous variants in genes involved in neuronal development and growth.Genet Res (Camb). 2019 Jun 13;101:e8. doi: 10.1017/S0016672319000065. Genet Res (Camb). 2019. PMID: 31190668 Free PMC article.
-
Analysis of exome-sequenced UK Biobank subjects implicates genes affecting risk of hyperlipidaemia.Mol Genet Metab. 2020 Sep-Oct;131(1-2):277-283. doi: 10.1016/j.ymgme.2020.07.009. Epub 2020 Jul 29. Mol Genet Metab. 2020. PMID: 32747172
-
Genetic Variants Associated with Hypertension Risk: Progress and Implications.Pulse (Basel). 2024 Jan 27;12(1):19-26. doi: 10.1159/000536505. eCollection 2024 Jan-Dec. Pulse (Basel). 2024. PMID: 38404912 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources